Profil
W.
Richey Neuman worked as an Assistant Professor at Perelman School of Medicine from 1997 to 2005.
He then worked as an Executive Director-Vaccines at Pfizer Inc. from 2005 to 2010.
After that, he worked as a Vice President-Medical Affairs at Teva Pharmaceuticals USA, Inc. and as a Vice President & Head-Medical Affairs at Hyperion Therapeutics, Inc. He also worked as a Medical Director at the University of Pennsylvania.
Neuman's education includes an undergraduate degree from Stanford University and a graduate degree from the University of California, Berkeley.
Anciens postes connus de W. Richey Neuman
| Sociétés | Poste | Fin |
|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2010 |
| Perelman School of Medicine | Corporate Officer/Principal | 01/01/2005 |
| University of Pennsylvania | Corporate Officer/Principal | - |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
Formation de W. Richey Neuman
| Stanford University | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
